Tigermed has made a significant leap in its global strategy by finalizing the acquisition of Micron, Inc., a prominent Japanese contract research organization (CRO) specializing in medical imaging and clinical trial services. This move highlights Tigermed’s ambition to strengthen its presence and capabilities in the vital Asia-Pacific region.
Tigermed Expands Global Reach With Micron Acquisition
With the acquisition now complete, Micron will become a central part of Tigermed Japan. Tigermed aims to leverage Micron’s experienced team and regional expertise to bolster its operations throughout Japan and the broader Asia-Pacific. This strategic integration reinforces Tigermed’s global network, now spanning over 180 locations and supporting more than 10,000 employees worldwide.
Micron’s Legacy in Medical Imaging and Clinical Trials
Founded in 2005 and headquartered in Tokyo, Micron stands as Japan’s first imaging CRO. The company boasts nearly two decades of experience and the largest imaging expert team in Asia. Key highlights of Micron’s track record include:
- Strong reputation for technological innovation in imaging biomarkers.
- Expertise in AI-powered imaging support.
- Support for over 250 clients and successful contributions to the approval of more than 40 drugs.
By focusing on cutting-edge techniques and client trust, Micron has played an instrumental role in advancing clinical research across the region.
Enhancing Medical Imaging Capabilities Across Asia-Pacific
The integration provides Tigermed with immediate access to long-established imaging excellence. The combined technologies and talent pool will reinforce Tigermed’s competitiveness in medical imaging and clinical services. As a result, the company is positioned to deliver comprehensive support for pharmaceutical, medical device, and personalized medicine ventures not only in Japan but across Asia-Pacific.
In summary, the acquisition of Micron marks a pivotal expansion for Tigermed in the global clinical research market. By joining forces, these companies will drive forward innovation, set higher standards for medical imaging, and contribute significantly to the progress of global healthcare research and development.
Don’t miss our latest Startup News: GosuBattles Grant Programme Boosts Grassroots Esports in Asia
